Boji Pharmaceutical (stock code: 300404.SZ) released its first-quarter performance with a net profit attributable to the parent company of 3.9 million yuan, a decrease of 76.38%.

Wisdom Financial News APP News, Boji Pharmaceuticals (300404.SZ) released its first quarter report for 2025, with the company's operating income at 139 million yuan, a decrease of 17.06% year-on-year. Net profit attributable to shareholders of the listed company was 3.9 million yuan, down 76.38% year-on-year. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.6979 million yuan, down 88.28% year-on-year. Basic earnings per share were 0.0102 yuan.